百济神州预计2025年实现经营利润为正 创新药企回暖在即?

21世纪经济报道
28 Feb

2月27日晚间,百济神州(纳斯达克代码:ONC;香港联交所代码:06160.HK;上交所代码:688235.SH)发布了2024年第四季度及全年的财务业绩,同时发布A股业绩快报公告。  财报显示,百济神州2024年在全球市场持续展示出强劲的增长势头,全年总收入达38亿美元,同比增长55%。产品收入成为推动营收增长的主要动力。  基于2024年财报业绩表现,百济神州首次给予财务指引,2025年全年...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10